Credit Suisse Healthcare Conference November 11 -12, 2014, Phoenix, AZ

Bill Rutherford – CFO and Executive Vice President Vic Campbell – Senior Vice President Dr. Ravi Chari – Vice President – Clinical Excellence Mark Kimbrough – Vice President – Investor Relations

22

2

FORWARD-LOOKING STATEMENTS AND NON-GAAP FINANCIAL MEASURES

This presentation may contain certain forward-looking statements provided by Company management. These statements are intended to be covered by the safe-harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that do not relate solely to historical or current facts, including statements regarding future operations, financial results, cash flows, costs and cost management initiatives, capital structure management, growth rates, and operational and strategic initiatives, and can also be identified by the use of words like “may,” “believe,” “will,” “expect,” “project,” “estimate,” “anticipate,” “intend,” “plan,” “initiative,” “continue” or words or phrases of similar meaning. These forward-looking statements speak only as of the date hereof and are based on our current plans and expectations and are subject to a number of known and unknown uncertainties and risks, many of which are beyond our control. These risks and uncertainties are described in headings such as “Risk Factors” in our annual report on Form 10-K for the year ended December 31, 2013 and other reports filed with the Securities and Exchange Commission. As a consequence, current plans, anticipated actions and future financial position and results of operations may differ significantly from those expressed in any forward-looking statements in today’s presentation. You are cautioned not to unduly rely on such forward-looking statements when evaluating the information presented and we do not intend to update any of these forward-looking statements.

The presentation may contain certain non-GAAP measures, including Adjusted EBITDA. The Company’s earnings releases for the year ended December 31, 2013, and for the quarter and nine months ended September 30, 2014, located on the Company’s investor relations page at www.hcahealthcare.com, include reconciliations of the difference between certain non-GAAP financial measures with the most directly comparable financial measure calculated in accordance with GAAP. These non-GAAP financial measures should not be considered alternatives to the GAAP financial measures.

References to “Company” used herein refer to HCA Holdings, Inc. and its affiliates, unless otherwise stated or indicated by context.

33

Most people know HCA as a hospital company, with leading market positions across the U.S.

Salt Lake City Denver

Kansas City

Miami/Fort Lauderdale/WPB

Dallas /Fort Worth

San Antonio

New Hampshire

Western Idaho

San Jose

Southern California

Las Vegas

Idaho Falls

Myrtle Beach

Trident / Charleston

JacksonvilleNorth Central Florida

OrlandoTreasure Coast

N-VA

Richmond

S-VA

Augusta

Tallahassee

Wichita

Oklahoma City

Central Louisiana

Lafayette

New OrleansPanhandle

El Paso

Corpus Christi

McAllen

Brownsville

TerreHaute

Frankfort

ChattanoogaNWGAAtlanta

Middle GA

Anchorage

Nashville

HoustonTampa

Austin

Central London

Note: Gold labels indicate top 10 domestic markets by 2013 Adjusted EBITDA.

44

HCA is the largest non-governmental hospital provider in the U.S. … and much more

#1 or #2 in key markets with market shares

ranging from ~ 20% to 40%

Operating in 17 of 25 fastest growing MSAs with

populations > 500,000

Provide ~ 4% - 5% of all U.S. hospital services

Leading hospital provider (1)…

Leader across a range of services …

One of the largest clinical networks, with over 35K

active physicians

Leader in oncology clinical trials, 2nd to MD

Anderson

Third largest acute inpatient psychiatric provider

A leading national player in ASCs

AND

(1) Based on most recently available data for each metric.

55

5

Percentage Change From Prior Year

Nine Months Ended Sept. 30, 2014

2.0%Equivalent

Admissions(1)

4.3%Revenue per

Equivalent Admission(1)

7.6%Revenues

12.6%

Adjusted EBITDA

32.8%

Net Income Attributable to

HCA Holdings, Inc.(2)

36.3%

Diluted Earnings Per Share(2)

(1) Same facility through 09/30/14 compared to prior year period

(2) Net income attributable to HCA Holdings, Inc. and diluted earning per share exclude losses (gains) on sales of facilities, losses on retirement of debt and legal claim costs.

66

Acquisitions

Cash Flow from Operations

Capital Expenditures

Special Dividends

Share Repurchases

$13.7 B

$6.6 B

$2.5 B

$3.2B

$2.75B

Cash Flow Trends since March 2011 IPO*

* HCA Holdings, Inc. cash flow data for the period from April 2011 through 3Q 2014

77

When thinking about growth strategies, we focus on a number of dimensions … in addition to clinical quality

Breadth and depth of services

Access points Capital deployment

Core services

Service Line Focus

High intensity and deep service capability E.g., TAVR, Trauma, Stroke network

E.g., Cardio, Neuro, ED Womens, Behavioral, Rehab

10 hospitals3 free-standing EDs43 medical group locations11 urgent care centers

88

HCA States Economic Indicators – Favorable Trending% Change in Key Economic Indicators

Weak Favorable

-2.5% 9.7%Real GDP

2013 YoY Growth

2.57%

1.84%

2.12%

Median of HCA’s Top 6

States

US Average

Range of HCA’s Top 6 States

US Range75th Percentile of HCA States

1.5% 7.6%Personal Income

2013 YoY Growth

3.07%

2.57%

2.83%

-34.2% 47.8%

Single Family Housing Permits Start

April 2014 YTD over PY

6.13%

-0.70%

6.50%

-6.0% 13.0%

State General Sales & Gross Receipt Taxes

2013 YoY Growth

6.56%

3.88%

5.80%

-0.79%-4.3% 2.1%

Birth Rate 2013 YoY Growth

0.00%-0.78%

0.5% -2.5%Unemployment

May 2014 over PY

-1.50%

-1.20%

-1.35%

HCA Top States:•California•Colorado

•Florida•Kansas

•Tennessee•Texas

99

Clinical Excellence is about Reducing Negative Clinical Variation

CE is our approach to clinical performance improvement that asks a physician led team to use clinical evidence to change physician practice choices and behavior to reduce negative clinical variation

HCA has created clinical data systems to measure and monitor clinical performance and a knowledge center to establish and share best evidenced care and practices

HCA achieves CE by having the team leading the care initiative take ownership and be accountable for performance improvement

We believe our CE initiatives differentiate our hospitals in the market as a premier clinical organization through:

• Collaborating with physicians to align practice choices with best practice• Teaching facility leaders to leverage HCA’s disciplined operational management culture to achieve the same rigor

around clinical performance improvement• Improving patient outcomes, patient safety and patient care

1Includes YOY impact for CE initiatives selected 7 care lines: AMI, CABG, Sepsis, Hip/Knee, Spine and Stroke

2013

Full YearCY 2014

Through June 30th

Lives Saved1 688 746

Mortality Rate Reduction 4.6% 9.2%

Complications Avoided 1,175 624

Complication Rate Reduction 8% 11%

Length of Stay days avoided 33,531 21,995

Reduction in average LOS 0.35 0.40Source: MedPAR and Company data

1010

We are confident that our core strengths will continue to position us for future success

Strongoperatingculture

Deep andexperiencedleadership

Financialstrength

Scale

Strong,diversifiedassets and

markets

Credit Suisse Healthcare Conference November 11 -12, 2014, Phoenix, AZ

Bill Rutherford – CFO and Executive Vice President Vic Campbell – Senior Vice President Dr. Ravi Chari – Vice President – Clinical Excellence Mark Kimbrough – Vice President – Investor Relations